V.1: Potential and challenges, 444p.; v.2: Efficacy, safety and clinical evaluation I, 493p.; v.3: Efficacy, safety and clinical evaluation II, 437p.; v.4: Antioxidants and nutraceuticals, 399p.; v.5: Immune-modulation and vaccine adjuvants, 441p.; v.6: Extraction, isolation and characterization, 437p.; v.7: Structural modification and drug development, 335p.; v.8: Quality control and standardization, 344p.
CONTENTS NOTE
Text of Note
V. 1. Potential & challenges --; v. 2. Efficacy, safety & clinical evaluation I --; v. 3. Efficacy, safety & clinical evaluation II --; v. 4. Antioxidants & nutraceuticals --; v. 5. Immune-modulation & vaccine adjuvants --; v. 6. Extraction, isolation & characterization --; v. 7. Structural modifications & drug development --; v. 8. Quality control & standardization